| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $5.93B | $5.36B | $4.61B | $4.60B | $4.12B |
| Cost of Revenue | $2.67B | $2.47B | $2.11B | $1.82B | $1.75B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $1.79B | $1.69B | $1.91B | $2.11B | $1.57B |
| SG&A | $979.13M | $919.10M | $857.42M | $953.26M | $710.64M |
| Operating Income | -$532.17M | -$787.29M | -$1.40B | -$1.40B | -$702.07M |
| Interest Expense | – | – | $22.02M | $21.46M | $17.68M |
| Tax Expense | $9.35M | $25.63M | $28.06M | $28.96M | $13.58M |
| Net Income | -$460.49M | -$697.86M | -$1.32B | -$1.43B | -$487.95M |
| EPS (basic) | -0.2700 | -0.4200 | -0.8200 | -0.8900 | -0.3100 |
| EPS (diluted) | -0.2700 | -0.4200 | -0.8200 | -0.8900 | -0.3100 |
| Shares (diluted) | $1.69B | $1.66B | $1.61B | $1.61B | $1.56B |